News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Absci shares spike 30% in IPO debut, valuing Washington state biotech company at nearly $2B
Just over a year after going public, Absci stocks are continuing to grow. The Vancouver, Washington based company now is valued at almost $2 billion.
Eliem Therapeutics files for IPO as another Seattle-area biotech firm set to go public
Eliem Therapeutics, a Redmond, Washington based biotech company has filed for IPO. The filing follows two rounds of funding which took place earlier in 2021,
Seattle startup Lumen Biosciences to build algae manufacturing plant in former bakery
Lumen Bioscience, a Seattle-based biotech company announced it will be expanding its operations and moving to Seattle’s Wallingford neighborhood to continue manufacturing proteins found in
Absci’s IPO reflects booming biotech market and growing PNW life sciences industry
In a growing IPO market, AbSci, Vancouver, A Washington-based biotech company prepares for a public offering, joining additional Washington state biotech startups in the public
Report: Seattle’s life sciences industry continues to boom
Funding from VCs for Seattle’s life science industry grew 266% during Q1 2021 in comparison with Q1 last year. This makes Seattle the fastest-growing life
Seattle-based Icosavax, which is developing COVID-19 vaccines, files for IPO 4 years after launch
Earlier this month, Icosavax, a Seattle-based biotech company that originally launched from the University of Washington, filed for IPO. Founded in 2017, Icosavax develops vaccines